Company · Healthcare · AI
AI backbone for the future of healthcare revenue assurance
Every investor coverage indicates participated in a round Arintra raised.
Investors whose own portfolio pages list Arintra, even though we haven't found any coverage of the round yet.
| Investor | Listed on |
|---|---|
| Ten13 | its portfolio page ↗ |
Companies Arintra acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Nitesh Shroff | Co-founder and CEO | letsdatascience.com, Ten13 |
Stories naming Arintra. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Healthcare AI vendor Arintra has banked $25m in Series B funding, led by Define Ventures, as prior backers such as Peak XV Partners, Y Combinator and others return; total backing now stands at $51m.
Ten13's monthly newsletter reports its first institutional mandate via Queensland's QVCDF, new seed investments in OneMRI and Source, follow-ons in Arintra and Everlab, and portfolio progress including Go1, Qsic, Pearler and After.com.
TEN13's investor letter celebrates passing $100 million deployed, plus fresh backing for iion and Switchboard, team promotions, AutoGrab's overseas growth and NZ-arm sale, and the Mr Yum–Me&U merger.
TEN13 announces Joel Pobar, an Anthropic engineering leader formerly at Meta, as its first Venture Partner, reinforcing the firm's AI investing focus; its early bets include Rockfish Data, Arintra and Qsic.
Ten13's year-end post recaps nine new portfolio additions, follow-on support for existing holdings, the Mr Yum and Me&U merger, Go1's Blinkist acquisition, Smileyscope's FDA clearance, and community events.
Also Ten13·OIF Ventures portfolio·TechCrunch Australia·SmartCompany·Startup Daily·SmartCompany·SmartCompany·Startup Daily·Startup Daily·Startup Daily·Forbes Australia